CERO THERAPEUTICS HOLDINGS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.88 million shares for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2025-11-19
- CERO THERAPEUTICS HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 2.88M shares.
- CERO THERAPEUTICS HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 881.03K shares.
- CERO THERAPEUTICS HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 6.44M shares.
- CERO THERAPEUTICS HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 30.67M shares.
- CERO THERAPEUTICS HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 19.69K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 1 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 1 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 4 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 5 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 5 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 7 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 8 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 8 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 11 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 2.88M shares 10-Q · filed 2025-11-19 | 2.88M shares 10-Q · filed 2025-11-19 | |||||||||||||
| 2025-06-30 | 881.03K shares 10-Q · filed 2025-08-22 | 881.03K shares 10-Q · filed 2025-08-22 | |||||||||||||
| 2025-03-31 | 6.44M shares 10-Q · filed 2025-05-15 | ||||||||||||||
| 2024-12-31 | 1.57M shares 10-K · filed 2025-04-15 | 19.69K shares 10-Q · filed 2025-05-15 | |||||||||||||
| 2024-09-30 | 77.77K shares 10-Q · filed 2025-11-19 | 156.06M shares 10-Q/A · filed 2024-11-20 | |||||||||||||
| 2024-06-30 | 8.25K shares 10-Q · filed 2025-08-22 | 17.02M shares 10-Q · filed 2024-08-14 | |||||||||||||
| 2024-03-31 | 160.71K shares 10-Q · filed 2025-05-15 | 16.60M shares 10-Q · filed 2024-05-17 | |||||||||||||
| 2024-02-13 | 985.00 shares 10-Q · filed 2025-11-19 | 30.55M shares 10-Q · filed 2024-05-17 | |||||||||||||
| 2023-12-31 | 19.69K shares 10-K · filed 2025-04-15 | ||||||||||||||
| 2023-09-30 | 30.66M shares 10-Q/A · filed 2024-11-20 | ||||||||||||||
| 2023-06-30 | 30.66M shares 10-Q · filed 2024-08-14 | ||||||||||||||
| 2023-03-31 | 30.67M shares 10-Q · filed 2024-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |